Neumora Therapeutics Inc. (NMRA) Live Share Price, Invest From India

Neumora Therapeutics Inc. Stock Performance

as on August 1, 2026 at 2:15 pm IST

Day's Low
$1.48
Day's Price Range
$1.61
$1.61
8.07%
Downside
52 Week's Low
52 Week's High
$0.83
52-Week Price Range
$3.65
$1.61
48.43%
Downside
126.71%
Upside

Neumora Therapeutics Inc. share price movements today

Previous Close: $1.65
Open: $1.52
Volume: 2.4M
Day's Low - High: $1.48 - $1.61
52 Week Low - High: $0.83 - $3.65

Neumora Therapeutics Inc. Historical Returns

1 Month Return: -0.62 %
3 Month Return: -34.02 %
1 Year Return: + 3.21 %
3 Year Return: 0 %
5 Year Return: 0 %

Neumora Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Neumora Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$305.7M

EPS (TTM)

-0.9166

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-218.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-148.74%

Neumora Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neumora Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Neumora Therapeutics Inc.	BUY	$305.7M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$40.9B	554.78%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.3B	136.68%	28.66	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$76.0B	32.72%	16.98	29.65%	NA

Stock Returns calculator for Neumora Therapeutics Inc. Stock including INR - Dollar returns

The Neumora Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Neumora Therapeutics Inc. investment value today

Current value as on today

₹1,12,469

Returns

₹12,469

(+12.47%)

Returns from Neumora Therapeutics Inc. Stock

₹3,205 (+3.21%)

Dollar Impact

₹9,264 (+9.26%)

Analyst Recommendation on Neumora Therapeutics Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Neumora Therapeutics Inc.. Average target price of $6.28

Neumora Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Neumora Therapeutics Inc..

What analysts predicted

74.36%UPSIDE

Target Price

$6.28

Current Price

$1.61

Analyzed by

12 Analysts

Target

$6.28

Neumora Therapeutics Inc. target price $6.28, a slight upside of 74.36% compared to current price of $1.61. According to 12 analysts rating.

Indian Investors' Interest in Neumora Therapeutics Inc. Stock

Search interest for Neumora Therapeutics Inc. Stock has decreased by -65% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 2, 2026 to August 1, 2026

Change:-65% versus previous 30 day period

Neumora Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-	-	-	-	-5	-	0
Operating Income	-50	-60	-63	-76	-62	-70	-54	-57	-58	-52
EBITDA	-108	-53	-58	-72	-58	-67	-52	-55	-57	-51
Interest Expense	-	-	-	-	-	-	-	0	2	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-108	-53	-58	-72	-58	-67	-52	-56	-59	-53
Income Tax Expense	0	-6	0	0	-	0	0	-	-	0
Net Income	-108	-53	-58	-72	-58	-67	-52	-56	-59	-53
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Neumora Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-1	-2	0	-	-5
Operating Income	-95	-237	-135	-188	-263	-241
EBITDA	-95	-236	-130	-234	-242	-233
Interest Expense	-	-	-	-	-	3
Depreciation	0	0	0	0	0	0
Income Before Tax	-99	-237	-130	-235	-243	-236
Income Tax Expense	0	0	-4	0	0	0
Net Income	-99	-237	-130	-235	-243	-236
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Neumora Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-53	-58	-72	-58	-67	-52	-56	-59	-53
Operating Cash Flow	-42	-56	-33	-50	-59	-52	-46	-47	-46
Investing Cash Flow	-150	21	156	-98	44	30	51	42	0
Financing Cash Flow	1	2	1	15	-	18	0	58	10
Change in Cash	-191	-32	125	-133	-15	-3	4	53	-35

Neumora Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-99	-237	-130	-235	-243	-236
Operating Cash Flow	-26	-75	-114	-163	-182	-206
Investing Cash Flow	-11	0	-168	64	-70	168
Financing Cash Flow	230	293	115	231	21	77
Change in Cash	192	217	-167	133	-231	39

Global Institutional Holdings in Neumora Therapeutics Inc.

Funds	Holdings
Wellcome Trust Ltd	1.81%
Siren, L.L.C.	4.65%
SoftBank Group Corp	3.33%
Wellcome Trust Ltd	1.81%
ICONIQ Capital, LLC	1.4%

See all

Insights on Neumora Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, NMRA stock has moved up by 8.1%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 412.0% return, outperforming this stock by 408.8%

About Neumora Therapeutics Inc.

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in Phase 1b clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-861 and NMRA-898, a M4 muscarinic receptor positive allosteric modulators (PAMs) for schizophrenia and other neuropsychiatric disorders. In addition, the company's preclinical phase product includes NMRA-GCase, an activator program for the treatment of Parkinson's Disease; NMRA-CK1d, a casein kinase 1 isoform delta (CK1d) inhibitor program for Amyotrophic Lateral Sclerosis; and NMRA-215 a brain-penetrant oral NLRP3 inhibitor for the treatment of obesity. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.

Organisation	Neumora Therapeutics Inc.
Headquarters	260 Arsenal Place, Watertown, MA, United States, 02472
Industry	Biotechnology
CEO	Mr. Paul L. Berns
E-voting on shares	Click here to vote

Key Management of Neumora Therapeutics Inc.

Name	Title
Dr. Joshua Pinto Ph.D.	President
Dr. Daljit Singh Aurora Pharm.D.	Chief Operationg & Development officer
Mr. Michael Lee Milligan	CFO & Principal Accounting Officer
Helen Rubinstein	Head of Investor Relations
Dr. Paul Yeung M.D., M.P.H.	Senior Vice President of Clinical Development
Mr. Paul L. Berns	Chairman & CEO
Dr. Nicholas Brandon Ph.D.	Chief Scientific Officer
Mr. Pablo Gersberg	Chief Information Officer
Mr. Jason G. Duncan J.D.	Chief Legal & Administrative Officer
Ms. Amy Sullivan	Chief Human Resources Officer

FAQs

What is Neumora Therapeutics Inc. share price today?

Neumora Therapeutics Inc. share price today is $1.61 as on August 1, 2026 at 8:45 am IST at the close of the market. Neumora Therapeutics Inc. share today touched a day high of $1.61 and a low of $1.48.

What is the 52 week high and 52 week low for Neumora Therapeutics Inc. share?

Neumora Therapeutics Inc. share touched a 52 week high of $3.65 on February 18, 2026 and a 52 week low of $0.83 on June 15, 2026. Neumora Therapeutics Inc. stock price today i.e. August 1, 2026 at 8:45 am IST is closed at $1.61,which is 55.89% down from its 52 week high and 93.93% up from its 52 week low.

What is Neumora Therapeutics Inc.'s market capitalisation today?

Neumora Therapeutics Inc. market capitalisation is $0.00T as on August 1, 2026 at 8:45 am IST.

How to invest in Neumora Therapeutics Inc. Stock (NMRA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neumora Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neumora Therapeutics Inc. Shares that will get you 0.9317 shares as per Neumora Therapeutics Inc. share price of $1.61 per share as on August 1, 2026 at 8:45 am IST.

What is the minimum amount required to buy Neumora Therapeutics Inc. Stock (NMRA) from India?

Indian investors can start investing in Neumora Therapeutics Inc. (NMRA) shares with as little as ₹95.38 or $1 (as of August 1, 2026 at 1:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Neumora Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on August 1, 2026 at 1:39 pm IST). Based on Neumora Therapeutics Inc. share’s latest price of $1.61 as on August 1, 2026 at 8:45 am IST, you will get 6.2112 shares of Neumora Therapeutics Inc.. Learn more about fractional shares .